Smith, Graham & Co., Investment Advisors, LP Prestige Consumer Healthcare Inc. Transaction History
Smith, Graham & Co., Investment Advisors, LP
- $867 Million
- Q4 2023
A detailed history of Smith, Graham & Co., Investment Advisors, LP transactions in Prestige Consumer Healthcare Inc. stock. As of the latest transaction made, Smith, Graham & Co., Investment Advisors, LP holds 130,887 shares of PBH stock, worth $11.4 Million. This represents 0.92% of its overall portfolio holdings.
Number of Shares
130,887
Previous 131,695
0.61%
Holding current value
$11.4 Million
Previous $7.53 Million
6.39%
% of portfolio
0.92%
Previous 0.94%
Shares
12 transactions
Others Institutions Holding PBH
# of Institutions
342Shares Held
50.7MCall Options Held
6.3KPut Options Held
0-
Black Rock Inc. New York, NY8.28MShares$720 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.68MShares$494 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.96MShares$257 Million0.05% of portfolio
-
Ariel Investments, LLC Chicago, IL2.78MShares$242 Million2.25% of portfolio
-
Macquarie Group LTD Australia, C32.67MShares$233 Million0.21% of portfolio
About Prestige Consumer Healthcare Inc.
- Ticker PBH
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,762,600
- Market Cap $4.33B
- Description
- Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...